Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.

[1]  Xiaogang Du,et al.  Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants. , 2007, Antiviral research.

[2]  Ming Wang,et al.  Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model. , 2007, Vaccine.

[3]  P. Jiang,et al.  Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. , 2006, Veterinary immunology and immunopathology.

[4]  Huijun Lu,et al.  Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus. , 2006, Journal of virological methods.

[5]  M. Grubman,et al.  Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. , 2006, Vaccine.

[6]  H. Bao,et al.  Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. , 2005, Vaccine.

[7]  J. Mascola,et al.  Neutralizing Antibodies Elicited by Immunization of Monkeys with DNA Plasmids and Recombinant Adenoviral Vectors Expressing Human Immunodeficiency Virus Type 1 Proteins , 2005, Journal of Virology.

[8]  M. Tang,et al.  Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. , 2004, Vaccine.

[9]  Min Wu,et al.  High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha. , 2004, Biochemical and biophysical research communications.

[10]  M. Grubman,et al.  Novel Viral Disease Control Strategy: Adenovirus Expressing Alpha Interferon Rapidly Protects Swine from Foot-and-Mouth Disease , 2003, Journal of Virology.

[11]  P. Mason,et al.  Molecular basis of pathogenesis of FMDV. , 2003, Virus research.

[12]  V. Cull,et al.  Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice , 2002, Gene Therapy.

[13]  T. Di Pucchio,et al.  Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model1 , 2002, The Journal of Immunology.

[14]  F. Brown,et al.  Effective synthetic peptide vaccine for foot-and-mouth disease in swine. , 2002, Vaccine.

[15]  G. Sachdeva,et al.  Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. , 2002, The Journal of infectious diseases.

[16]  C. Biron.  Interferons α and β as Immune Regulators—A New Look , 2001 .

[17]  F. Belardelli,et al.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.

[18]  Manmohan J. Singh,et al.  Advances in vaccine adjuvants , 1999, Nature Biotechnology.

[19]  F. Sobrino,et al.  Synthetic peptide vaccines: foot-and-mouth disease virus as a model. , 1999, Developments in biological standardization.

[20]  E. Domingo,et al.  A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants , 1997, Journal of virology.

[21]  S. Nandi,et al.  Biochemical characterization of FMDV A10 and A22 subtypes by PAGE and IEF. , 1997, Comparative immunology, microbiology and infectious diseases.

[22]  P. Lehmann,et al.  Induction of TH1 and TH2 Immunity in Neonatal Mice , 1996, Science.

[23]  G. Belsham.  Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure , 1993, Progress in Biophysics and Molecular Biology.

[24]  R. Meloen,et al.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. , 1992, Immunology.

[25]  F. Brown.  New approaches to vaccination against foot-and-mouth disease. , 1992, Vaccine.

[26]  S. Barteling,et al.  Developments in foot-and-mouth disease vaccines. , 1991, Vaccine.

[27]  R. DiMarchi,et al.  A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. , 1991, Journal of immunology.

[28]  D. Stuart,et al.  Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus , 1990, Nature.

[29]  Richard A. Houghten,et al.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence , 1982, Nature.